Publications

“Evolution of Data Management Metrics at Novartis – A Short History” - 2001 DIA Clinical Data Management conference in Atlantic City

“Which Crystal Ball Shall I Pick?” (resource forecasting methodology) - 2003 DIA European Clinical Data Management conference in Basle

“Resource Forecasting Challenges in an Early Stopping Trial” - 2004 DIA European Clinical Data Management / Validation / IT conference in Amsterdam

Abstract (oral presentation by co-author): “Rapid Scale-up of a Data Team for Early Closeout of a Large Trial” - 2004 DIA European Clinical Data Management / Validation / IT conference in Amsterdam

“Data Warehouse – Lessons Learnt from an Academic Collaboration” - 2005 DIA European Clinical Data Management / Validation / IT / eClinical conference in Prague

“Improving Communication and Information Sharing to Boost Trial Outcomes and Reduce Time to Market” – 2009, 2^nd Annual Conference, The Evolution of Clinical Data Management in Munich

“Implementing SDTM in a Semi-Virtual Oncology-Focused Biotechnology Company” – 2010 CDISC European Interchange in London

“Development & Implementation of a Statistical Programming Environment in a Biotechnology Company” – 2010 PhUSE Conference in Berlin

Ibrahim NK, Yariz KO, Bondarenko I, Manikhas A, Semiglazov V, Alyasova A, Komisarenko V, Shparyk Y, Murray JL, Jones D, Senderovich S, Chau A, Erlandsson F, Acton G, Pegram M. “Randomized phase II trial of letrozole plus anti-MUC1 antibody AS1402 in hormone receptor-positive locally advanced or metastatic breast cancer.” Clin Cancer Res. 2011 Nov 1;17(21):6822-30

“Optimising the effectiveness of your trial design” – 2011, Informa Life Sciences’ Conference on Improving Comparator Studies in Berlin

“Round Table Discussion: How to choose a comparator: assessing the strategies for comparator choice” – 2011, Informa Life Sciences’ Conference on Improving Comparator Studies in Berlin

“IVRS Intelligence – Understanding and Harnessing the Power” - 2011, Evening Masterclass at Informa Life Sciences’ Conference on Clinical Trials Supplies and Packaging in Berlin

“Introduction to statistical evaluation of stability data: What you always wanted to understand” – 2012, 1-Day Post Conference Workshop at Informa Life Sciences’ Annual Conference on Stability Testing for Pharmaceuticals in Berlin

“Challenges in developing cancer treatments in small companies” – 2012, PSI One-Day Scientific Meeting in London

“The statistician’s toolbox: how it can assist with risk-based approach planning” – 2012, Informa Life Sciences Quality Risk Management for GCP in Clinical Development Conference in Berlin

“Automating the production of SDTM datasets” – 2014, Xtalks Life Science Webinars (Hosted by Omnicomm Systems)

Tore Bach-Gansmo, Cristina Nanni, Peter T. Nieh, Lucia Zanoni, Tronde Velde Bogsrud, Heidi Sletten, Katrine Andersen Korsan, J. Kieboom, Funmilayo I. Tade, Oluwaseun Odewole, Albert Chau, Penelope Ward, Mark M. Goodman, Stefano Fanti, David M. Schuster, Frode Willoch. “Multisite Experience of the Safety, Detection Rate and Diagnostic Performance of Fluciclovine (18F) Positron Emission Tomography/Computerized Tomography Imaging in the Staging of Biochemically Recurrent Prostate Cancer” The Journal of Urology 2017, 197(3),:676-683.

Albert Chau, Peter Gardiner, Patrick Colletti, Hossein Jadvar. "Diagnostic Performance of 18F-Fluciclovine in Detection of Prostate Cancer Bone Metastases" Clinical Nuclear Medicine: July 2018 - Volume 43 - Issue 7 - p e226–e231.